**California ABC Cracks Down: Kratom and 7-OH Declared Illegal on Alcohol-Licensed Premises**

California ABC Cracks Down: Kratom and 7-OH Declared Illegal on Alcohol-Licensed Premises

Sacramento, CA – February 28, 2026 – The California Department of Alcoholic Beverage Control (ABC) has issued a significant directive, declaring kratom and its potent derivative, 7-hydroxymitragynine (7-OH), illegal for sale on any alcohol-licensed premises across the state. This move intensifies California's stance against these substances, following earlier warnings from public health authorities.

What Happened The California ABC's enforcement effort stems from a statewide consumer warning issued by the California Department of Public Health (CDPH) on October 24, 2025. This advisory explicitly declared that foods, dietary supplements, and medical drugs containing kratom or 7-OH are dangerous and illegal to sell or manufacture for consumption in California. The ABC is now actively ensuring its licensees comply with this prohibition, with a strong emphasis on removing these products from store shelves immediately. This action builds upon a January 16, 2026, announcement by the CDPH, collaborating with ABC and CDTFA, to remind consumers and retailers of the dangers and illegality of these products.

Why It Matters to Kratom Merchants and Consumers This declaration carries substantial weight for any business holding an ABC license that previously sold kratom or 7-OH products. These include a wide array of establishments, from bars and restaurants to convenience stores and gas stations that also sell alcohol. Licensees are now mandated to cease sales and remove all such products, or face severe administrative disciplinary actions, which could range from suspension to outright revocation of their liquor license. For consumers, this means a significant reduction in retail access points for kratom and 7-OH products within California. The ABC's proactive enforcement signals a clear message: the state is committed to eradicating these substances from its alcohol-regulated market.

Compliance Implications The ABC's enforcement is not based on a new, specific kratom law, but rather on the classification of kratom and 7-OH products as "adulterated" under existing federal and state law, specifically the Sherman Food, Drug, and Cosmetic Act. The CDPH has linked these products to serious health risks, including addiction, overdose, and death, citing six overdose fatalities in Los Angeles County, some of which involved alcohol consumption. This context highlights the regulatory imperative behind the ABC's actions, underscoring the perceived public health threat posed by these substances, especially when combined with alcohol. The advisory emphasizes that these products have not been tested for safety, consistency, effectiveness, or accurate labeling, nor have they received FDA approval for sale.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance For merchants operating in the high-risk kratom industry, this California ruling serves as a critical reminder of the paramount importance of stringent compliance. Even in jurisdictions where kratom remains legal, robust adherence to best practices is essential.

1. Certificates of Analysis (COAs): Always demand and review comprehensive COAs from third-party, ISO-accredited laboratories for every batch of kratom product. These COAs must verify the absence of heavy metals, pesticides, microbial contaminants, and provide accurate alkaloid profiles.
2. Lab Testing for Potency and Purity: Beyond basic screening, ensure products are tested for the presence and concentration of active alkaloids, particularly mitragynine and 7-hydroxymitragynine. The heightened potency of concentrated 7-OH (up to 13 times stronger than morphine) makes accurate labeling and testing for this compound especially critical to prevent misrepresentation and potential harm.
3. Regulatory Compliance: Stay informed about local, state, and federal regulations. The California situation demonstrates how existing food and drug laws can be leveraged to restrict or ban kratom products, even without specific "kratom bans." Merchants must understand that the lack of FDA approval for kratom as a dietary supplement or food additive leaves the industry vulnerable to such interpretations and enforcement actions.

This latest development in California reinforces the need for unparalleled diligence in product sourcing, testing, and understanding the evolving legal landscape to navigate the complexities of the kratom market successfully.